GLOBAL PH Stock

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - OTC Markets 22:59:56 05/06/2026 +03 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for GLOBAL PH 0.00% +60.20%
Current month+60.20%
1 month+60.20%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: GLOBAL PH

Market Cap 4.72M 4.08M 3.76M 3.52M 6.59M 449M 6.7M 44.38M 17.3M 218M 17.72M 17.35M 757M P/E Ratio 2006
-20.5x
P/E Ratio 2007 -4.23x
Enterprise Value 2.04M 1.76M 1.62M 1.52M 2.85M 194M 2.89M 19.19M 7.48M 94.46M 7.66M 7.5M 327M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
Current month+60.20%
1 month+60.20%
3 months+60.20%
6 months+60.20%
Current year+60.20%
1 month 0.06
Extreme 0.0593
0.08
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.15
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.05M 1.89M 1.77M 3.32M 226M 3.37M 22.32M 8.7M 110M 8.92M 8.73M 381M 2.82M 2.43M 2.24M 2.1M 3.94M 268M 4M 26.49M 10.33M 130M 10.58M 10.35M 452M
Net income -1.23M -1.07M -982K -920K -1.72M -117M -1.75M -11.6M -4.52M -57.11M -4.63M -4.53M -198M -3.3M -2.85M -2.63M -2.46M -4.61M -314M -4.68M -31M -12.09M -153M -12.38M -12.12M -528M
Net Debt -2.68 -2.31 -2.13 -2 -3.74 -254.59 -3.8 -25.17 -9.81 -123.92 -10.05 -9.84 -429.07 -2.68 -2.32 -2.13 -2 -3.74 -254.85 -3.8 -25.2 -9.82 -124.04 -10.06 -9.85 -429.5
Logo GLOBAL PH
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
217
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GBLP Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!